Eclitasertib (DNL-758) is a potent receptor-interacting protein kinase 1 (RIPK1) inhibitor with an IC50 of <1 µμ (From patent WO2017136727A2, example 42)[1].
[1]. Anthony A. ESTRADA, et al. Compounds, compositions and methods. WO2017136727A2.
| 规格 | 价格 | 库存 | 数量 | 操作 |
|---|---|---|---|---|
| 1mg | ¥896.00 | 现货 | 1 | |
| 5mg | ¥2,610.00 | 现货 | 1 | |
| 10mg | ¥4,140.00 | 现货 | 1 | |
| 10mM (in 1mL DMSO) | ¥2,173.00 | 现货 | 1 |
















Eclitasertib (DNL-758) is a potent receptor-interacting protein kinase 1 (RIPK1) inhibitor with an IC50 of <1 µμ (From patent WO2017136727A2, example 42)[1].
[1]. Anthony A. ESTRADA, et al. Compounds, compositions and methods. WO2017136727A2.